Suchergebnisse - "Kashii, Masafumi"

PubPharm (11)

1

Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2023

von Kashii, M. | Kamatani, T. | Nagayama, Y. | +3

2

Effects of prior osteoporosis treatment on 12-month treatment response of romosozumab in patients with postmenopausal osteoporosis

enthalten in: Joint bone spine | 2021

von Ebina, K. | Tsuboi, H. | Nagayama, Y. | +13

3

Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosis

enthalten in: Modern rheumatology | 2021

von Ebina, K. | Hashimoto, J. | Kashii, M. | +10

4

Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis

enthalten in: Bone | 2020

von Ebina, K. | Hirao, M. | Tsuboi, H. | +11

5

Combined effect of teriparatide and an anti-RANKL monoclonal antibody on bone defect regeneration in mice with glucocorticoid-induced osteoporosis

enthalten in: Bone | 2020

von Etani, Y. | Ebina, K. | Hirao, M. | +11

6

The combined effects of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in ovariectomized mice

enthalten in: Bone | 2020

von Kitaguchi, K. | Kashii, M. | Ebina, K. | +7

7

Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis

enthalten in: Journal of bone and mineral metabolism | 2018

von Ebina, K. | Hirao, M. | Hashimoto, J. | +7

8

Effects of single or combination therapy of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in mice

enthalten in: Bone | 2018

von Kitaguchi, K. | Kashii, M. | Ebina, K. | +7

9

The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis

enthalten in: Journal of bone and mineral metabolism | 2017

von Ebina, K. | Hashimoto, J. | Kashii, M. | +5

10

Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis

enthalten in: The spine journal : official journal of the North American Spine Society | 2015

von Sugiura, T. | Kashii, M. | Matsuo, Y. | +5

CommentIn: Spine J. 2015 Feb 1;15(2):307-8. - PMID 25598280